These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38914769)

  • 1. Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).
    Keane G; Lam M; Braat A; Bruijnen R; Kaufmann N; de Jong H; Smits M
    Cardiovasc Intervent Radiol; 2024 Sep; 47(9):1224-1236. PubMed ID: 38914769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on: Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).
    Bargellini I; Iezzi R; Mosconi C; Spreafico C; Crocetti L
    Cardiovasc Intervent Radiol; 2024 Sep; 47(9):1237-1238. PubMed ID: 39090355
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
    Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioembolisation in Europe: A Survey Amongst CIRSE Members.
    Reinders MTM; Mees E; Powerski MJ; Bruijnen RCG; van den Bosch MAAJ; Lam MGEH; Smits MLJ
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1579-1589. PubMed ID: 29740687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
    Toskich BB; Liu DM
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Young S; Craig P; Golzarian J
    Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present Status of Thyroid Ablation in Europe: An International Survey among the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Members.
    Mauri G; Monfardini L; Lucertini E; Cazzato RL; Pereira P; Orsi F; Sconfienza LM
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1385-1390. PubMed ID: 35945348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study.
    Kolligs F; Arnold D; Golfieri R; Pech M; Peynircioglu B; Pfammatter T; Ronot M; Sangro B; Schaefer N; Maleux G; Munneke G; Pereira H; Zeka B; de Jong N; Helmberger T;
    JHEP Rep; 2023 Feb; 5(2):100633. PubMed ID: 36593888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. French Interventional Radiology Centers' Uptake of Transradial Approach and Outpatient Hepatocellular Carcinoma Intra-Arterial Treatments.
    Grégory J; Ronot M; Laurent V; Chabrot P; de Baere T; Chevallier P; Vilgrain V; Aubé C;
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):432-440. PubMed ID: 37930400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
    Maleux G; Albrecht T; Arnold D; Bargellini I; Cianni R; Helmberger T; Kolligs F; Munneke G; Peynircioglu B; Sangro B; Schaefer N; Pereira H; Zeka B; de Jong N; Bilbao JI;
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):852-867. PubMed ID: 36914788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France.
    Loffroy R; Ronot M; Greget M; Bouvier A; Mastier C; Sengel C; Tselikas L; Arnold D; Maleux G; Pelage JP; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; Urdániz M; Kaufmann N; Bilbao JI; Helmberger T; Vilgrain V;
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):36-49. PubMed ID: 32975600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.
    Ierardi AM; Angileri SA; Patella F; Panella S; Lucchina N; Petre EN; Pinto A; Franceschelli G; Carrafiello G; Cornalba G; Sofocleous CT
    Med Oncol; 2017 Jan; 34(1):11. PubMed ID: 28008570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).
    Spreafico C; Maccauro M; Mazzaferro V; Chiesa C
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):634-8. PubMed ID: 24477451
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?
    Hendlisz A; Sclafani F
    Curr Opin Oncol; 2021 Jul; 33(4):351-352. PubMed ID: 33966002
    [No Abstract]   [Full Text] [Related]  

  • 15. [International comparison of radiological aspects of the new German S3 guideline on hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Pereira PL; Vogl TJ; Helmberger T
    Radiologe; 2022 Mar; 62(3):253-262. PubMed ID: 35181824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.
    Malone CD; Gibby W; Tsai R; Kim SK; Lancia S; Akinwande O; Ramaswamy RS
    J Vasc Interv Radiol; 2020 May; 31(5):701-709. PubMed ID: 32127318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interventional Radiology (IR) Gender Gap: A Prospective Online Survey by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
    Wah TM; Belli AM
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1241-1253. PubMed ID: 29789874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ; Scheurig-Münkler C; Banzer J; Schnapauff D; Hamm B; Gebauer B
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
    Gangi A; Shah J; Hatfield N; Smith J; Sweeney J; Choi J; El-Haddad G; Biebel B; Parikh N; Arslan B; Hoffe SE; Frakes JM; Springett GM; Anaya DA; Malafa M; Chen DT; Chen Y; Kim RD; Shridhar R; Kis B
    J Vasc Interv Radiol; 2018 Aug; 29(8):1101-1108. PubMed ID: 30042074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.